Proxy Votes Now

Home › Funds › PENN SERIES FUNDS INC › Small Cap Index Fund

Small Cap Index Fund proxy voting record 2025-2026

Fund family: PENN SERIES FUNDS INC · Filed by PENN SERIES FUNDS INC (CIK 702340) · SEC series S000022078

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,461 with, 55 against, 10 abstentions (not counted as with management); 18 items carried no recommendation. Shareholder proposals: 14 FOR, 38 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with PENN SERIES FUNDS INC as a whole

The same two figures as PENN SERIES FUNDS INC’s manager page (42,846 ballot items across 19 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsPENN SERIES FUNDS INCItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.3%14,98093.7%37,596
Backed environmental and social shareholder proposals at US companiesn/a610.0%422

Where this fund voted differently from most PENN SERIES FUNDS INC funds

Each ballot item this fund voted is set against the votes of the other PENN SERIES FUNDS INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most PENN SERIES FUNDS INC funds on 3 items (3.7% of the 82 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost PENN SERIES FUNDS INC fundsMgmtResult
Ligand Pharmaceuticals Incorporated2026-06-05Election of Directors: Jason M. AryehWithholdFOR — 3 of 3 PENN SERIES FUNDS INC fundsAgainstElected, 82.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: John W. KuoWithholdFOR — 3 of 3 PENN SERIES FUNDS INC fundsAgainstPassed (calculated), 100.0% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungForWITHHOLD — 2 of 3 PENN SERIES FUNDS INC fundsForPassed (calculated), 85.5% support

Download all 3 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.9% of this fund’s 15,526 such votes could be given a sector; the other 1,419 (9.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,13630.1%
Consumer Discretionary2,738240.9%
Health Care2,426110.5%
Industrials1,58050.3%
Technology1,43240.3%
Real Estate88610.1%
Energy61000.0%
Utilities38400.0%
Consumer Staples25552.0%
Basic Materials24500.0%
Miscellaneous21000.0%
Telecommunications20510.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,50023
Say-on-Pay1,8372
Audit-related1,8230
Compensation6350
Corporate Governance45217
Capital Structure2203
Extraordinary Transactions2003
Shareholder Rights and Defenses491
Other110
Other Social Issues30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
agilon health, inc.March 17, 2026$1M20
Bloom Energy CorporationMay 21, 2026$1M80
Guardant Health, Inc.June 17, 2026$475,29950
Nextracker Inc.August 18, 2025$384,03350
Glaukos CorporationMay 28, 2026$371,00140
BridgeBio Pharma, Inc.June 22, 2026$321,43170
The Ensign Group, Inc.May 13, 2026$282,15760
American Healthcare REIT, Inc.June 24, 2026$278,736110

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalAgainstFor
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II Directors, each to serve for a term of three years until the 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalWithholdFor
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalAgainstFor
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 12, 2026Group 1 Automotive, Inc.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalAgainstFor
June 3, 2026Resideo Technologies, Inc.Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

15,738 ballot items at 2,033 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small Cap Index Fund voted at 2,033 shareholder meetings of 1,913 companies, on 15,738 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 55 times. Its most frequent area of disagreement was director elections (23 of its votes against management). It voted FOR 26.9% of the 52 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than PENN SERIES FUNDS INC's funds as a whole (91.3% against 93.7%). It voted differently from most PENN SERIES FUNDS INC funds on 3 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of PENN SERIES FUNDS INC’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.